2009
DOI: 10.1038/nrc2718
|View full text |Cite
|
Sign up to set email alerts
|

p53 and E2f: partners in life and death

Abstract: During tumour development cells sustain mutations that disrupt normal mechanisms controlling proliferation. Remarkably, the Rb-E2f and MDM2-p53 pathways are both defective in most, if not all, human tumours, which underscores the crucial role of these pathways in regulating cell cycle progression and viability. A simple interpretation of the observation that both pathways are deregulated is that they function independently in the control of cell fate. However, a large body of evidence indicates that, in additi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

17
426
0
10

Year Published

2011
2011
2023
2023

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 435 publications
(453 citation statements)
references
References 128 publications
17
426
0
10
Order By: Relevance
“…Ablation of Bax or over‐expression of the anti‐apoptotic factors (Bcl‐2 or Bcl‐X L ) result in disruption of spermatogenesis because of eliminated first‐wave apoptosis. Interestingly, E2F1 has been shown to regulate these factors either directly or via p53 (reviewed in (Polager & Ginsberg, 2009)). An absence of E2F1‐mediated activation of these genes is a possible cause of the decreased first‐wave apoptosis of spermatogonia in the E2F1 −/− testes.…”
Section: Discussionmentioning
confidence: 99%
“…Ablation of Bax or over‐expression of the anti‐apoptotic factors (Bcl‐2 or Bcl‐X L ) result in disruption of spermatogenesis because of eliminated first‐wave apoptosis. Interestingly, E2F1 has been shown to regulate these factors either directly or via p53 (reviewed in (Polager & Ginsberg, 2009)). An absence of E2F1‐mediated activation of these genes is a possible cause of the decreased first‐wave apoptosis of spermatogonia in the E2F1 −/− testes.…”
Section: Discussionmentioning
confidence: 99%
“…E2F1 is a transcription factor involved in cell-cycle control and apoptosis, whose expression is often dysregulated in human tumors. 32,33 Upon DNA damage, E2F1 is phosphorylated by CHK1 and CHK2 and subsequently induces transcription of p73 and its target genes to initiate p53-independent apoptosis. 34 Studies on murine embryonic fibroblasts indicated that the AHR inhibits E2F1-induced apoptosis, probably due to a physical interaction of both transcription factors.…”
Section: Discussionmentioning
confidence: 99%
“…Transcriptional pathways known to modulate levels of the Bcl-2 protein family (including that of Noxa) involve p53 or E2F-1. 25,26 E2F-1 differs from that of other E2F family members due to its ability to regulate not only cell-cycle progression but also apoptosis as it directly induces the expression of p73, of caspase 3 and 7 and of some pro-apoptotic Bcl-2 family members. [27][28][29][30][31][32][33][34] We show here that E2F-1 is a major contributor of caspase-dependent induction of Noxa in response to ABT-737 treatment.…”
mentioning
confidence: 99%